Cesium implant radiation for recurrent cervical or uterine cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests a type of internal radiation (cesium implant) to treat cancer that has come back in the vagina after previous pelvic radiation. The goal is to save the organ while treating the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Confirmed vaginal recurrence of cervical or endometrial cancer (cancer came back in the vagina after previous treatment)
- Previous pelvic radiation therapy for your original cancer
- Cancer that can be seen on imaging (CT, MRI, or physical exam) and measures at least 1 cm
- Good overall health status (able to perform daily activities with minimal assistance)
- No other active cancers or recent cancer diagnosis in the past 3 years (except skin cancer or in-situ cervical/bladder cancer)
- No spread to lymph nodes or distant organs at the time of enrollment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether carbon ion radiation can control mucosal melanoma in the lower female genital tract. It may help by targeting the tumor with high-precision radiation while trying to protect nearby organs like the bladder and rectum.
This trial tests a special type of radiation that is given in small, spaced-out beams to treat gynecologic cancers (like cervical or uterine cancer). It is for patients who cannot get standard internal radiation (brachytherapy) because of unusual anatomy, large tumors, a narrow vagina, or anesthesia risks.
This trial tests a shorter course of radiation combined with chemotherapy (hypofractionated radiochemotherapy) for women with advanced cervical cancer. It may help reduce treatment time while still effectively targeting the tumor.
This study tests giving radiation again to treat a cancer that has returned in the pelvic area (including the groin) when surgery isn’t a good option. It may help control the tumor while trying to protect nearby organs such as the small intestine.
This trial tests whether giving radiation to a smaller area of the pelvis is enough to treat stage IIb cervical cancer, while sparing more healthy tissue. It may help reduce side effects and improve your quality of life during and after treatment.
This trial tests a faster, high-dose radiation treatment for cervical cancer that is given directly into the uterus. It aims to see if this approach is safe and effective for women with certain stages of the disease.
Hear when a new Gynecologic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.